{"id":"W2178569306","doi":"10.1007/s12325-015-0261-x","title":"Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease","year":2015,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Metformin; Liraglutide; Kidney disease; Intensive care medicine; Glycemic; Diabetes mellitus; Guideline; Alogliptin; Type 2 Diabetes Mellitus; Type 2 diabetes; Saxagliptin; Internal medicine; Pharmacology; Sitagliptin; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001417182,0.0009381844,0.002436508,0.003391675,0.000251068,0.001278062,0.001238038,0.00110595,0.004671147],"category_scores_gemma":[0.002749091,0.0003728442,0.001623829,0.003836731,0.0003337214,0.001288111,0.0007670702,0.001541643,0.0009775492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000609084,"about_ca_system_score_gemma":0.002339106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002111574,"about_ca_topic_score_gemma":0.003893693,"domain_scores_codex":[0.999341,0.0001067189,0.00021692,0.00008079706,0.0002156286,0.00003895389],"domain_scores_gemma":[0.9981695,0.001039076,0.0004262557,0.00002975455,0.000273989,0.00006135788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002814527,0.00008503355,0.0004530547,0.114569,0.0006602046,0.0002000942,0.00006896755,0.0002843335,0.001008734,0.001988773,0.02252384,0.8578766],"study_design_scores_gemma":[0.0001229352,0.0002937157,0.003604695,0.04855258,0.002531833,0.001351598,0.0001079848,0.0001800396,0.0005072868,0.002185205,0.940504,0.0000581924],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008520239,0.9990407,0.00007814794,0.0001989275,0.00009708553,0.000007297138,0.00006602146,0.00000448022,0.000422178],"genre_scores_gemma":[0.0004422251,0.9988635,0.0002232685,0.0001968979,0.0001062139,0.000006345127,0.00005684972,8.767108e-7,0.0001038932],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004671147,"threshold_uncertainty_score":0.01562655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1538682301300158,"score_gpt":0.4110486792444433,"score_spread":0.2571804491144275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}